Biomarkers can help a treatment team to determine the best treatment for a patient, see how the patient is responding, and assist in creating a care plan. New tumor markers frequently become available and may not be reflected on this list.
- AKT
- CPTAC RCC Clusters
- HIF1α
- HIF1α, HIF2α
- IMmotion 150 Angio Signature Myeloid
- IMmotion 150 T effector signature
- IMmotion 151 Cluster
- IMmotion Myeloid Signature
- JAVELIN Renal 101 Angio signature
- JAVELIN Renal 101 Immuno signature
- KRAS
- KRAS and MCL-1
- MCL-1,MDM2
- MDM2, MDM4,
- MDM4, NRF2,
- p53
- survivin (BIRC5)
- XIAP